Serum 25-hydroxyvitamin D levels and the risk of idiopathic central precocious puberty in girls
Autor(a) principal: | |
---|---|
Data de Publicação: | 2023 |
Outros Autores: | , , , |
Tipo de documento: | Artigo |
Idioma: | eng |
Título da fonte: | Clinics |
Texto Completo: | https://www.revistas.usp.br/clinics/article/view/214049 |
Resumo: | Introduction: Prior studies have found inconsistent results regarding the relationship between vitamin D status and Idiopathic Central Precocious Puberty (ICPP). Objective: To assess the role of serum 25-hydroxyvitamin D (25 [OH]D) levels in ICPP development. Method: The authors retrospectively collected data from 221 girls with ICPP and 144 healthy girls between January 2017 and December 2019. The participants’ serum 25(OH)D levels were measured using an automatic chemiluminescence method, and the association between serum 25(OH)D levels and the risk of ICPP was assessed using multivariate logistic regression analysis. Odds Ratios (OR) with 95% Confidence Intervals (95% CI) were calculated as effect estimates. Results: Serum 25(OH)D levels in the ICPP group were significantly lower than those in healthy controls (p < 0.001). Multivariate analysis indicated that girls with insufficient vitamin D levels (OR = 0.201; 95% CI 0.094–0.428; p < 0.001) and sufficient vitamin D levels (OR = 0.141; 95% CI 0.053–0.375; p < 0.001) both had a lower risk of ICPP than girls with vitamin D deficiency. Moreover, the authors found that the height (p = 0.014), weight (p = 0.014), breast stage (p = 0.010), mother's height (p < 0.001), and luteinizing hormone/follicle-stimulating hormone ratio (p = 0.010) in girls with ICPP could be associated with levels of vitamin D. Conclusion: This study found that a low serum 25(OH)D level is an independent risk factor for ICPP, and several characteristics of girls with ICPP could be affected by their vitamin D status.: |
id |
USP-19_bcddb0c69156575692a9541da2a020af |
---|---|
oai_identifier_str |
oai:revistas.usp.br:article/214049 |
network_acronym_str |
USP-19 |
network_name_str |
Clinics |
repository_id_str |
|
spelling |
Serum 25-hydroxyvitamin D levels and the risk of idiopathic central precocious puberty in girlsIdiopathic central precocious pubertySerum 25-hydroxyvitamin DGirlsRisk factorsIntroduction: Prior studies have found inconsistent results regarding the relationship between vitamin D status and Idiopathic Central Precocious Puberty (ICPP). Objective: To assess the role of serum 25-hydroxyvitamin D (25 [OH]D) levels in ICPP development. Method: The authors retrospectively collected data from 221 girls with ICPP and 144 healthy girls between January 2017 and December 2019. The participants’ serum 25(OH)D levels were measured using an automatic chemiluminescence method, and the association between serum 25(OH)D levels and the risk of ICPP was assessed using multivariate logistic regression analysis. Odds Ratios (OR) with 95% Confidence Intervals (95% CI) were calculated as effect estimates. Results: Serum 25(OH)D levels in the ICPP group were significantly lower than those in healthy controls (p < 0.001). Multivariate analysis indicated that girls with insufficient vitamin D levels (OR = 0.201; 95% CI 0.094–0.428; p < 0.001) and sufficient vitamin D levels (OR = 0.141; 95% CI 0.053–0.375; p < 0.001) both had a lower risk of ICPP than girls with vitamin D deficiency. Moreover, the authors found that the height (p = 0.014), weight (p = 0.014), breast stage (p = 0.010), mother's height (p < 0.001), and luteinizing hormone/follicle-stimulating hormone ratio (p = 0.010) in girls with ICPP could be associated with levels of vitamin D. Conclusion: This study found that a low serum 25(OH)D level is an independent risk factor for ICPP, and several characteristics of girls with ICPP could be affected by their vitamin D status.:Hospital das Clínicas, Faculdade de Medicina, Universidade de São Paulo2023-07-05info:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersionapplication/pdfhttps://www.revistas.usp.br/clinics/article/view/21404910.1016/j.clinsp.2023.100244Clinics; Vol. 78 (2023); 100244Clinics; v. 78 (2023); 100244Clinics; Vol. 78 (2023); 1002441980-53221807-5932reponame:Clinicsinstname:Universidade de São Paulo (USP)instacron:USPenghttps://www.revistas.usp.br/clinics/article/view/214049/196280Copyright (c) 2023 Clinicsinfo:eu-repo/semantics/openAccessGan, Dong-MeiFang, JieZhang, Ping-PingZhao, Yu-DanXu, Ya-Nan2023-07-06T13:05:40Zoai:revistas.usp.br:article/214049Revistahttps://www.revistas.usp.br/clinicsPUBhttps://www.revistas.usp.br/clinics/oai||clinics@hc.fm.usp.br1980-53221807-5932opendoar:2023-07-06T13:05:40Clinics - Universidade de São Paulo (USP)false |
dc.title.none.fl_str_mv |
Serum 25-hydroxyvitamin D levels and the risk of idiopathic central precocious puberty in girls |
title |
Serum 25-hydroxyvitamin D levels and the risk of idiopathic central precocious puberty in girls |
spellingShingle |
Serum 25-hydroxyvitamin D levels and the risk of idiopathic central precocious puberty in girls Gan, Dong-Mei Idiopathic central precocious puberty Serum 25-hydroxyvitamin D Girls Risk factors |
title_short |
Serum 25-hydroxyvitamin D levels and the risk of idiopathic central precocious puberty in girls |
title_full |
Serum 25-hydroxyvitamin D levels and the risk of idiopathic central precocious puberty in girls |
title_fullStr |
Serum 25-hydroxyvitamin D levels and the risk of idiopathic central precocious puberty in girls |
title_full_unstemmed |
Serum 25-hydroxyvitamin D levels and the risk of idiopathic central precocious puberty in girls |
title_sort |
Serum 25-hydroxyvitamin D levels and the risk of idiopathic central precocious puberty in girls |
author |
Gan, Dong-Mei |
author_facet |
Gan, Dong-Mei Fang, Jie Zhang, Ping-Ping Zhao, Yu-Dan Xu, Ya-Nan |
author_role |
author |
author2 |
Fang, Jie Zhang, Ping-Ping Zhao, Yu-Dan Xu, Ya-Nan |
author2_role |
author author author author |
dc.contributor.author.fl_str_mv |
Gan, Dong-Mei Fang, Jie Zhang, Ping-Ping Zhao, Yu-Dan Xu, Ya-Nan |
dc.subject.por.fl_str_mv |
Idiopathic central precocious puberty Serum 25-hydroxyvitamin D Girls Risk factors |
topic |
Idiopathic central precocious puberty Serum 25-hydroxyvitamin D Girls Risk factors |
description |
Introduction: Prior studies have found inconsistent results regarding the relationship between vitamin D status and Idiopathic Central Precocious Puberty (ICPP). Objective: To assess the role of serum 25-hydroxyvitamin D (25 [OH]D) levels in ICPP development. Method: The authors retrospectively collected data from 221 girls with ICPP and 144 healthy girls between January 2017 and December 2019. The participants’ serum 25(OH)D levels were measured using an automatic chemiluminescence method, and the association between serum 25(OH)D levels and the risk of ICPP was assessed using multivariate logistic regression analysis. Odds Ratios (OR) with 95% Confidence Intervals (95% CI) were calculated as effect estimates. Results: Serum 25(OH)D levels in the ICPP group were significantly lower than those in healthy controls (p < 0.001). Multivariate analysis indicated that girls with insufficient vitamin D levels (OR = 0.201; 95% CI 0.094–0.428; p < 0.001) and sufficient vitamin D levels (OR = 0.141; 95% CI 0.053–0.375; p < 0.001) both had a lower risk of ICPP than girls with vitamin D deficiency. Moreover, the authors found that the height (p = 0.014), weight (p = 0.014), breast stage (p = 0.010), mother's height (p < 0.001), and luteinizing hormone/follicle-stimulating hormone ratio (p = 0.010) in girls with ICPP could be associated with levels of vitamin D. Conclusion: This study found that a low serum 25(OH)D level is an independent risk factor for ICPP, and several characteristics of girls with ICPP could be affected by their vitamin D status.: |
publishDate |
2023 |
dc.date.none.fl_str_mv |
2023-07-05 |
dc.type.driver.fl_str_mv |
info:eu-repo/semantics/article info:eu-repo/semantics/publishedVersion |
format |
article |
status_str |
publishedVersion |
dc.identifier.uri.fl_str_mv |
https://www.revistas.usp.br/clinics/article/view/214049 10.1016/j.clinsp.2023.100244 |
url |
https://www.revistas.usp.br/clinics/article/view/214049 |
identifier_str_mv |
10.1016/j.clinsp.2023.100244 |
dc.language.iso.fl_str_mv |
eng |
language |
eng |
dc.relation.none.fl_str_mv |
https://www.revistas.usp.br/clinics/article/view/214049/196280 |
dc.rights.driver.fl_str_mv |
Copyright (c) 2023 Clinics info:eu-repo/semantics/openAccess |
rights_invalid_str_mv |
Copyright (c) 2023 Clinics |
eu_rights_str_mv |
openAccess |
dc.format.none.fl_str_mv |
application/pdf |
dc.publisher.none.fl_str_mv |
Hospital das Clínicas, Faculdade de Medicina, Universidade de São Paulo |
publisher.none.fl_str_mv |
Hospital das Clínicas, Faculdade de Medicina, Universidade de São Paulo |
dc.source.none.fl_str_mv |
Clinics; Vol. 78 (2023); 100244 Clinics; v. 78 (2023); 100244 Clinics; Vol. 78 (2023); 100244 1980-5322 1807-5932 reponame:Clinics instname:Universidade de São Paulo (USP) instacron:USP |
instname_str |
Universidade de São Paulo (USP) |
instacron_str |
USP |
institution |
USP |
reponame_str |
Clinics |
collection |
Clinics |
repository.name.fl_str_mv |
Clinics - Universidade de São Paulo (USP) |
repository.mail.fl_str_mv |
||clinics@hc.fm.usp.br |
_version_ |
1800222767422898176 |